Monday, July 26, 2010

Avoiding the "Donut Hole"



Even if you are not interested in geriatrics, still take Dr. Remington’s class….


As the summer goes on, I continue making my MTM calls. But the more calls I do, the more I realize that a comment complaint among the members is hitting the “donut-hole”. It is inevitable though, as your age increases so do the number of your prescriptions. Even though more and more generic drugs are coming to market, medication costs are still on the rise. But this is where pharmacists can play a crucial role to members (or “patients” for the rest of you).

As a student it’s hard to believe that we can really impact a patient’s drug therapy or reduce the overall costs of their medications. But we can! This is why I say take Dr. Remington’s class – even if you don’t have any interest in geriatrics. I can honestly say I am a peds person all the way and still benefited greatly from her class.

In Dr. Remington’s class, she gives an assignment which requires you do reduce a patient’s medication. Now, avoiding the donut-hole has nothing to do with what the patient actually pays at the pharmacy but with the actual drug cost. For example a member is receiving pantoprazole and pays the lowest copay since this is a generic medication ($10 for 90-day supply). So is there a reason to switch this patient to another PPI? Yes! If you look at the actual cost of the medication (wholesale cost) a 90-day supply of pantoprazole is $319.95, where a 90-day supply of omeprazole is $149.98. As a result, switching the member to omeprazole would save $679.88 per year. And that’s just ONE medication!

As you can see, modifying a member’s drug therapy - even just one medication - can make a huge difference. Think about how much we as pharmacists can do for a member in cutting their prescription costs to help them avoid the donut hole.

Deadlines Looming


Things are stressful at the moment. In 2 days, my group (composed of Pharmacy, Dentistry, and Social Work students) are responsible to submit a grant proposal and give a presentation about Alzheimer’s Disease. This is the final objective of the MCRiT summer practicum: participation in a “virtual group research project” . To guide us, we’ve been paired with Charles Burant MD, Ph.D, a professor in the School of Medicine who has been OUTSTANDING as a mentor. Unfortunately, we’ve only been given 2 weeks to make this project happen, and unfortunately, life doesn’t just stop when you have deadlines looming.

My observation is that research can start off incredibly slow and dry - when you’re being trained, trying to put a project together, or coming up with a hypothesis- , but can become quite stressful whenever deadlines approach ( ie annual reports, renewal of grants, presentation of work thus far). I’ve also discovered research doesn’t always end when the clock strikes 5 pm. These past few days, my day started with clinic but then afterwards have been filled with meetings and reading up on Alzheimer’s Disease in my free time. Some days there have been meetings that extended late into the evening to ensure we get our work done.

And your personal life doesn’t stop too. I went to a wedding on Saturday and I’m attending another in 2 weeks.

Though I’m super busy working on my portion of the Virtual Group project – I’m in charge of the data analysis ( statistics again!) and figuring out which statistical test is appropriate, patient safety ( to pass IRB) and the estimated budget (to hypothetically hire a Primary Investigator, study coordinator, purchase supplies, etc) – I really wanted to write this post and share what I think happens annually in research, and that is reporting and presenting what you’ve done all year. We’ve had seminars for each step of the research process – now it’s time to incorporate everything and demonstrate what we’ve learned in the past 9 weeks!

This is a picture of our whiteboard from a late evening brainstorming session to develop a testable hypothesis about Alzheimer’s Disease.

A little help

I have a small dilemma. At the end of the internship each intern is required to make a presentation to the directors, managers, residents and remaining interns. Mine is of course the last one...because you save the best for last. Unfortunately I have no idea which of my dozens of projects I should actually present on that will also engage the crowd. One of my favorite projects happen to be my simplest project in which I know I could bring it to life and have tons of fun with it. On the other hand it borders on un-professionalism, but should I really worry about that?
I have about 15 different projects that I am involved with out of those 15 none of them are actually completed. This is due to no fault of my own here a simple project can span into a year-long headache. I knew this before coming and accepted that things I started would most likely be finished by someone else and maybe within a year I will see the fruits of my labor. The biggest project that I will try to get updates on during the school year is the Creative Alternatives packaging. I found alternative packaging for this program through a product called DisPill. It's actually really innovative and all signs point to them moving forward with the packaging in the coming months. More than just finding it through a google search I had to work with our IT department to ensure that the programing would integrate with our current computer system. Discussing the operational impact of packaging change and the costs per patient associated with the new packaging. I also had the opportunity to work with producers of DisPill to change their software to benefit our target population. I have a problem presenting this as my final presentation as it only has application here at Johns Hopkins. I want to present something that no matter where their career takes them they can think back and remember the presentation. It looks as though I will have to search through my projects and find the one...

Friday, July 23, 2010

It's all about the people

I just wanted to spotlight some of the great people I have had the opportunity to work with as this will be the last week we are all together. This year there were 24 interns accepted into the Johns Hopkins Internship program and I am grateful for the opportunity to meet each and every one of them. I won't go through all of them but I did want to talk about a few people who have made my experience incredible.
The preceptors are the people that make it possible for us to have this program. My preceptor is Nathan Thompson the Director of Outpatient Pharmacy. Other notable preceptors include: Yvonne LeBlanc (Clinical Applications Manager), Jim DiPaula (Operations Manager), Bridgette Thomas (PharmIS Manager), Krista Decker (Quality & Safety Manager), Brendan Reichert (PharmIS Director), Brian Pinto (Drug Use and Policy Director), and Edina Avdic (Pharmacoeconomics Manager). I was able to spend at least one full day with each of these preceptors and want to thank them for their time. A lot of other people have acted as a reference and guide this summer and hopefully mentors as my career progress these people include; John Hopkins (that's his real name, no relation) and Jim Van Daniker who both serve as the business managers for the outpatient pharmacy and Dan Ashby (Director of Pharmacy) I have to send a special thanks to Luis Simbala who is not a pharmacist but taught me so much the summer about Microsoft programs that Bill Gates himself should write this guy a check.
The interns helped me keep my sanity and made me laugh every day. First up is Abbie Shallop who we all know since she goes to school with us. It was great to get to know Abbie more of the summer we had some great laughs together and I want to wish the best of luck on her marriage and hopes that she enjoys it before classes begin again. Then there is Rami Beiram who is like the big brother I always wanted. He is a third-year student at Harding University by way of Atlanta, Georgia, he and I share the same humor and make quite the comedic duo. Then there's Tamara Fawall, the little sister I never wanted. Actually she's great her and I have the same exact birthday so you can imagine what a female version of me is like to deal with. Tamara is also a third-year student at Rutger's University, I finally found my Jersey girl. Without the three of them I would not have enjoyed myself nearly as much and I will keep in contact with all of them as we go forward, Abbie has no choice since I'll sit right next to her in class but the other two I will bother them through other media. This Monday will be our last day together as Rami heads back to Atlanta before heading back to school at Harding University. I swear... I'm not going to cry...

Thursday, July 22, 2010

IPSF-SEP Taiwan- Part IV

My last week in Taiwan came and went quickly. My schedule at the hospital this week included a variety of activities such as rounding with the ID team, evaluation of a new drug for addition into the formulary, and observation at the outpatient pharmacy (which is incredibly fast-paced, serving >2000 patients between 8am-10pm).

Taiwan has a national health insurance scheme and healthcare services are affordable and accessible to all its citizens. At Shuang Ho Hospital, patients pay a nominal registration fee of NT$150 (about US$5) for each physician appointment. There is no out-of-pocket cost for medications unless the patient is taking drugs that are not covered by the national health insurance. Private clinics are not common in Taiwan as most patients prefer going to larger hospitals.

Medications are dispensed in “prescription bags” which are about the size of a sheet of paper. These are labeled with standard information such as drug name/dose, patient’s name, DOB, prescriber’s name, pharmacy address and contact number, etc. There is also additional information such as common adverse effects, storage information, and tablet description. Labels would indicate the correct tablet shape, color, imprint, and scoring. Thus, patients are able to verify whether they received the correct medication. I think this is an excellent way of empowering patients and improving patient safety.

My SEP experience has been a rewarding one, both professionally and culturally. With ~15 SEP students in Taiwan this year, not only do I learn from Taiwanese students and pharmacists, I have also learned a lot from other students from Canada, UK, Singapore, Poland, etc.

And what’s next? Taipei to Singapore, and Singapore to Ann Arbor. I’ll be on the plane for close to 30 hours over the next 3 days!!

The New Era of 340B

It's been a bit since my last update. I know that my blog contains no pictures so I seem boring but I completely planned to upload pics soon. Then I had a serious disagreement with my iPhone and it decided to reset itself and delete everything that was in the phone over the past 5 months. Meaning that I lost all the pics I took this summer, I'll try to get some pics from the other interns and take more pics before the end of the internship, which is only a month away.
Enough complaining this Monday I was invited to the annual 340B Coalition Summit held in Washington, D.C. The conference attracts pharmacist, physicians, nurses and business managers from all over the country to discuss the future of 340B. The Affordable Care Act (ACA) or Health Care Reform is the first change to the 340B change since it's creation in 1992. To give a brief rundown on what exactly 340B is and how it relates to hospitals I will attempt to make it as painless as possible.
Almost every hospital participates in a form of charity. As health care professionals it is not in the nature of our job to turn away patients in need. When a hospital services a disproportionate number of patients who neither qualify for Medicare or Medicaid assistance that hospital outpatient pharmacy can now apply for the 340B program. The official percentage is 11.75% of your population must fit in this description of need. So now what? Say normally I purchase a bottle of Drug A for $1.00 and I normally sell that bottle of Drug A for $1.75, well my profit margin for that drug is $0.75. Now I am part of the 340B program and under this program I can purchase drugs for a deeply discounted price. For the same bottle of Drug A I can now buy it at a price of $0.75, well I am still going to sell it for normal price of $1.75. What changed? Well now my margin on the same product is now $1.00 compared to $0.75. The goal of this increased margin however is not to pocket the savings but put the savings back into the charity fund. This allows the hospital to either increase the number of patients they serve or close the gap in the dollar value of drugs given to patients without insurance. Also a few things to note 340B is that it is only used for outpatient drugs, not inpatient and only a few clinic drugs. 340B is important because like I said most hospitals have a form a charity it is beneficial to be part of the 340B program to increase your margins and close the gap in charitable funds and revenue collected.
Back to business the summit was actually over three days but I was only able to go to the first day. The two big questions that were going to be debated over the conference were: 1) if everyone is now covered in some form or another with insurance will their be a need for 340B? and 2) if manufactures can afford to offer 15-30% discounts on the drugs currently under the program than what kind of prices are they charging? Two great questions without solid answers. As health care providers it is in our best interest to serve our population any way possible without going broke and that's what 340B allows. What about the millions of Americans that health care reform leaves out, who still wont have insurance? All valid questions and this is just a small portion of the ACA. I bring attention to this because pharmacist play a crucial role in the years moving forward at least when it comes to 340B pharmacist have taken the leadership role and advocated for their patients which is great. When law is finally signed there could be substantial changes to 340B like getting is extended into the inpatient setting, it could disappear all together. I guess only time will tell...
P.S. - Love walking through the conference with my Johns Hopkins badge on, they treat you like a freakin rock star. No joke

Tuesday, July 20, 2010

A Taste of Grey's Anatomy in Ann Arbor


Have you ever watched those medical shows with those handsome doctors who talk oh so lovely to their patients to enroll them into a clinical trial they are conducting? Well that's what my life has been like this summer except for the lack of a McDreamy hair cut and the fooling around with medical interns in the on-call room.

These past 8 weeks, I've been at the Taubman General Medicine Clinic at the University of Michigan Health System Hospital doing a study with the Pharmacists and Physicians on where their patients go to obtain their prescription medications. Co-blogger Alex Tungol actually did a similar study 2 years ago with Dr. Erickson through the summer MCRiT program as well. This gives me the ability to compare my results with hers, after I analyze my data with statistics. It will be interesting to see if any trends have developed in the two years. It's been a while since I've taken Statistics (and I never knew how significant it is to research) so this provides an opportunity to freshen up in my Excel and SPSS programing. Once I get my results, Dr. Erickson and I will analyze it, make a research poster, write a paper on it, and hopefully get published in a scientific journal!

For this project, specifically we're looking at whether the Recession and the two year advertisement campaign of the $4 inexpensive generic programs offered by major chain pharmacies ( such as Kroger, Walmart, and Target) have had any effect on the behavior of general medicine patients of where they go to get their prescriptions filled. We'll also be able to see if these incentive program have lead to increased medication adherence and other prescription behaviors. Furthermore, this outcome research affects the Physicians and Pharmacists directly at the Taubman Medical Clinic because many have been pushing their patients to utilize these types of prescription programs.

My primary job these past 8 weeks have been to enroll patients into the study. I've been humbled to say the least. From this experience, I now understand how difficult it is to enroll patients into any study - whether it be a simple 15 minute psychology study or a complicated clinical trial involving a new experimental drug for cancer patients undergoing chemotherapy. What I found to be alarming is that there are thousands of studies that are going on at UofM right now, but each year many studies lose their funding because they do not enroll sufficient patients the grant requires for their federal funding. This explains why I'm always bombarded with fliers (and now e-mails) asking me to participate in a study with cash incentives or ipod giveaways. It's serious business. And quite stressful if you're the clinical coordinator in charge of getting enough patients for the study. Your funding depends on it!

My study required me to enroll ~200 patients. To say it bluntly, I've never been rejected so many times in my life. Some days were good, others were not so good. Great days were when I enrolled 17 patients into the study and walked out of the clinic triumphantly! But there were many days when I only got 4 or 5 patients in a span of six hours at clinic and left feeling dejected. I guess in research, some days things will go your way, but other days they won't. The important thing is to persevere, not quit, and plan for the unexpected. A quote by Louis Pasteur provides insight : "luck favors the prepared."

One thing this research project has allowed me to do is to talk to patients again - something I haven't done so much since my days working at a community pharmacy. I'll be the first to admit, I do not have McDreamy hair or a McSteamy body, but I love to talk with people. My chief duties was to provide informed consent - specifically that the study was completely voluntarily and that there would be no benefit for participating. Since there was no compensation, I had to win them over with my McTastic smile! :)

I learned as much from the patients as they learned from me. I met at clinic a professional baker who explained to me the science of baking by enlightening me with how it's as much science as art - do not add too much salt when baking bread or the yeast will die and your dough won't rise! I met at clinic a couple who crossed the Canadian border monthly to get some of their prescriptions because of the drastic savings. And I even ran into the Dean of Admissions of the College of Pharmacy, Dean Perry, at clinic! She graciously volunteered to participate in my study (see the re-enactment picture at the end of the post)!

To pass the time on those extra slow days, I created activities to keep myself busy. I read.....a lot, and I kept a journal each day at clinic to record my observations and my thoughts. This practice is a good habit to develop now in my young professional career - to write down every observation I see in research. They are great resources to go back to when I write my final report but also helped pass the time on those extra slow days of research. I've found research to be a slow, methodical, surgical process....but without this process there would be no good science that results from it. I'll be keeping Louis Pasteur's famous words in mind: Luck favors the prepared.




If anyone has questions about MCRiT send an e-mail to me at : cqtruong@umich.edu